[Asia Economy Reporter Jang Sehee] On the 1st, SillaJen announced the appointment of Joo Sang-eun, former CEO of Leo Pharma, and Lee Kwon-hee, formerly of Samsung Biologics' finance team, as managing directors.
The appointment of managing directors aims to oversee overall management and research activities, with their term lasting from today until June 30 of next year.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

